Nothing Special   »   [go: up one dir, main page]

Pinsky et al., 1996 - Google Patents

Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation.

Pinsky et al., 1996

View PDF
Document ID
16455271536238377215
Author
Pinsky D
Naka Y
Liao H
Oz M
Wagner D
Mayadas T
Johnson R
Hynes R
Heath M
Lawson C
Stern D
et al.
Publication year
Publication venue
The Journal of clinical investigation

External Links

Snippet

The period of hypoxia is an important priming event for the vascular dysfunction that accompanies reperfusion, with endothelial cells (ECs) and neutrophils (PMNs) playing a central role. We hypothesized that EC Weibel-Palade (WP) body exocytosis during the …
Continue reading at www.jci.org (PDF) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
Pinsky et al. Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation.
McMahon Red blood cell deformability, vasoactive mediators, and adhesion
US6316403B1 (en) Methods for treating an ischemic disorder and improving stroke outcome
Homeister et al. Effects of complement activation in the isolated heart. Role of the terminal complement components.
Kyriakides et al. Skeletal muscle reperfusion injury is mediated by neutrophils and the complement membrane attack complex
US8128963B2 (en) Methods for treating ischemic disorders using carbon monoxide
Miyagawa et al. Effects of transfected complement regulatory proteins, MCP, DAF, and MCP/DAF hybrid, on complement-mediated swine endothelial cell lysis
US7238469B2 (en) Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
EP0951292B1 (en) Treating an ischemic disorder and improving stroke outcome
Weyrich et al. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury.
Chrzanowska-Wodnicka et al. Rap1b is required for normal platelet function and hemostasis in mice
Maas et al. Endothelial cell PECAM-1 confers protection against endotoxic shock
Etingin et al. von Willebrand factor mediates platelet adhesion to virally infected endothelial cells.
WO1998013058A9 (en) Methods for treating an ischemic disorder and improving stroke outcome
AU2002318377A1 (en) Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
Gebrane-Younes et al. Heterogeneous distribution of Weibel-Palade bodies and von Willebrand factor along the porcine vascular tree.
Hughes et al. A novel ENU-generated truncation mutation lacking the spectrin-binding and C-terminal regulatory domains of Ank1 models severe hemolytic hereditary spherocytosis
Senis et al. Changes in the pattern of distribution of von Willebrand factor in rat aortic endothelial cells following thrombin generation in vivo
Yeatman et al. Human complement regulatory proteins protect swine lungs from xenogeneic injury
Murphy et al. In vitro aspects of erythropoiesis
Lau et al. The role of antibodies and von Willebrand factor in discordant pulmonary xenotransplantation
WO2001068131A1 (en) Blocking leukocyte emigration and inflammation by interfering with cd99/hec2
Seekamp et al. The effect of anti-L-selectin (EL-246) on remote lung injury after infrarenal ischemia/reperfusion
Michelson Flow cytometric analysis of platelets
Brenner et al. The influence of antibody and complement removal with a Ig-Therasorb column in a xenogeneic working heart model